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Abstract  Objective:  Many  patients  with  implantable  cardioverter  deﬁbrillators  experience
depressive  symptoms.  In  addition,  avoidance  behavior  is  a  common  problem  among  patients
with implantable  cardioverter  deﬁbrillators.  We  examined  the  association  between  avoidance
behaviors and  depressive  symptoms  in  patients  with  implantable  cardioverter  deﬁbrillators.
Method: We  conducted  a  single-center,  cross-sectional  study  with  self-completed  questionnaires
between  May  2010  and  March  2011.  We  measured  avoidance  behaviors  (avoidance  of  places,
avoidance  of  objects,  and  avoidance  of  situations)  and  depressive  symptoms  (using  the  Beck
Depression Inventory,  Version  II)  in  119  participants.  An  avoidance  behaviors  instrument  was
developed  for  this  study  and  we  conﬁrmed  its  internal  consistency  reliability.  Results: Ninety-
two (77.3%)  patients  were  aged  older  than  50  years,  and  86  (72.3%)  were  men.  Fifty-one  (42.9%)
patients reported  ‘‘avoidance  of  places’’,  34  (28.6%)  reported  ‘‘avoidance  of  objects’’,  and  63
(52.9%) reported  ‘‘avoidance  of  activity’’.  Avoidance  behavior  was  associated  with  increased
odds for  the  presence  of  depressive  symptoms  (OR  1.31;  95%  CI  1.06--1.62).  Conclusions:  This
was the  ﬁrst  study  to  identify  the  relationship  between  avoidance  behavior  and  depressive
symptoms  among  patients  with  implantable  cardioverter  deﬁbrillators;  however,  there  are  a
few methodological  limitations. de  Psicolog´ıa  Conductual.  Published  by  Elsevier  Espan˜a,  S.L.U.  This
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Conducta  de  evitación  asociada  a  síntomas  depresivos  en  pacientes  con
desﬁbriladores  cardioversores  implantables
Resumen  Objetivo:  Muchos  pacientes  con  desﬁbriladores  cardioversores  implantables  exper-
imentan síntomas  depresivos.  Además,  la  conducta  de  evitación  es  un  problema  común  entre
estos pacientes.  El  objetivo  fue  examinar  la  asociación  entre  las  conductas  de  evitación  y  sín-
tomas depresivos  en  pacientes  con  desﬁbriladores  cardioversores  implantables.  Método:  Se
llevó a  cabo  un  estudio  transversal  en  un  único  centro  entre  mayo  de  2010  y  marzo  de  2011.
Mediante  autoinformes  se  midieron  conductas  de  evitación  (evitación  a  lugares,  evitación  a
objetos y  evitación  a  situaciones)  y  síntomas  depresivos  (mediante  el  Inventario  de  Depresión
de Beck,  Versión  II)  en  119  participantes.  El  instrumento  de  evitación  se  desarrolló  para  este
estudio con  adecuada  ﬁabilidad  de  consistencia  interna.  Resultados:  Noventa  y  dos  pacientes
(77,3%)  tenían  más  de  50  an˜os  y  86  pacientes  (72,3%)  eran  hombres.  Cincuenta  y  un  pacientes
(42,9%) informaron  de  ‘‘evitación  a  lugares’’,  34  pacientes  (28,6%)  informaron  de  ‘‘evitación  a
objetos’’  y  63  pacientes  (52,9%)  informaron  ‘‘evitación  a  actividad’’.  La  conducta  de  evitación
se asoció  con  un  aumento  en  la  probabilidad  de  síntomas  depresivos  (OR  1,31;  IC  del  95%,  1,06-
1,62). Conclusiones:  Este  es  el  primer  estudio  para  identiﬁcar  la  relación  entre  la  conducta
de evitación  y  síntomas  depresivos  en  pacientes  portadores  de  desﬁbriladores  cardioversores
implantables,  aunque  existen  algunas  limitaciones  metodológicas.
© 2016  Asociacio´n  Espan˜ola  de  Psicolog´ıa  Conductual.  Publicado  por  Elsevier  Espan˜a,  S.L.U.
Este es  un  art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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PAn  implantable  cardioverter  deﬁbrillator  (ICD)  is  an  elec-
ronic  internal  device  that  can  detect  and  correct  fatal
rrhythmia.  The  use  of  ICDs,  including  the  cardiac  resyn-
hronization  therapy  deﬁbrillator  (CRT-D)  for  patients  with
eart  failure,  signiﬁcantly  reduces  mortality  from  sudden
ardiac  death  compared  with  anti-arrhythmic  drug  therapy
Alba  et  al.,  2013;  Chen,  Ling,  Kikuchi,  Yin,  &  Krucoff,  2013;
onnolly  et  al.,  2000;  Tan,  Wilton,  Kuriachan,  Sumner,  &
xner,  2014).  However,  some  patients  with  ICDs  experience
sychological  distress  due  to  fear  of  blast  or  strong  pain
y  electric  shock  (de  Ornelas  Maia,  Soares-Filho,  Pereira,
ardi,  &  Silva,  2013;  Heller,  Ormont,  Lidagoster,  Sciacca,  &
teinberg,  1998).  According  to  a  recent  systematic  review,
--41%  of  patients  reported  depressive  symptoms  and  8--63%
eported  anxiety  symptoms  (Magyar-Russell  et  al.,  2011).
Depressive  symptoms  are  a  particularly  difﬁcult  psycho-
ogical  problem  for  patients  with  ICDs.  Indeed,  11--28%  of
ll  such  patients  have  major  depressive  disorder  (Magyar-
ussell  et  al.,  2011)  that  follows  a  severe  clinical  course.
everal  studies  have  reported  that  depressive  symptoms
ere  a  risk  factor  for  poor  adherence  (Luyster,  Hughes,  &
unstad,  2009),  arrhythmic  episodes  (Tzeis  et  al.,  2011),
hantom  shock  (Starrenburg,  Kraaier,  Pedersen,  Scholten,  &
an  Der  Palen,  2014),  rehospitalization  (Shalaby,  Brumberg,
l-Saed,  &  Saba,  2012),  and  increased  mortality  rates  (van
en  Broek  et  al.,  2013;  Whang  et  al.,  2005).  In  contrast,
ome  earlier  studies  suggested  that  depressive  symptoms
re  predicted  by  being  younger,  being  female,  having  poor
ocial  support  (e.g.,  living  alone),  having  a  poor  physical
ondition  (e.g.,  presence  of  heart  failure),  and  electric
hock  events  among  patients  with  ICDs  (Morys´, Pa˛chalska,
ellwon,  &  Gruchała,  2016).  However,  the  personal  factorsPlease  cite  this  article  in  press  as:  Ichikura,  K.,  et  al.  Avoi
patients  with  implantable  cardioverter  deﬁbrillators.  Interna
http://dx.doi.org/10.1016/j.ijchp.2016.11.001
hat  are  related  to  depressive  symptoms  have  not  yet  been
ully  deﬁned,  although  factors  related  anxiety  symptoms
ave  been  increasingly  clariﬁed  (Sears  &  Conti,  2002).
W
s
oAvoidance  behavior  is  one  of  the  most  common  symp-
oms  for  patients  with  ICDs  (Godemann  et  al.,  2001,  2004;
ngles,  Sarina,  Kasparian,  &  Semsarian,  2013;  Morken  et  al.,
014).  Patients  with  avoidance  behaviors  characteristically
educe  their  routine  behaviors  such  as  using  cell  phones,
aking  showers,  or  going  out  because  they  fear  electric
hock  from  an  ICDs  (Cutitta  et  al.,  2014).  Indeed,  17%  of
atients  reported  ‘‘avoidance  of  places’’,  27%  reported
‘avoidance  of  objects’’,  and  39%  reported  ‘‘avoidance  of
ituations’’  (Lemon,  Edelman,  &  Kirkness,  2004).  Avoidance
ehavior  promotes  anxiety  and  is  a symptom  of  anxiety
isorders  such  as  panic  disorder  and  posttraumatic  stress  dis-
rder  (Godemann  et  al.,  2004;  Pauli,  Wiedemann,  Dengler,
laumann-Benninghoff,  &  Kühlkamp,  1999;  Sears  &  Conti,
002;  von  Känel,  Baumert,  Kolb,  Cho,  &  Ladwig,  2011).  In  the
eneral  population,  research  on  behavioral  activation  treat-
ent  has  suggested  that  avoidance  behaviors  are  related
o  depressive  symptoms  (Jacobson,  Martell,  &  Dimidjian,
006;  Jacobson  &  Newman,  2014).  However,  no  study  has
xamined  the  association  between  avoidance  behaviors  and
epressive  symptoms  in  patients  with  ICDs;  therefore,  we
xamined  (1)  the  frequency  of  avoidance  behaviors  and  (2)
he  association  between  avoidance  behaviors  and  depressive
ymptoms  in  patients  with  ICDs.  Our  primary  hypothesis  was
hat  patients  who  have  a  strong  avoidance  tendency  would
e  more  likely  to  have  depressive  symptoms.
ethod
articipantsdance  behavior  associated  with  depressive  symptoms  in
tional  Journal  of  Clinical  and  Health  Psychology  (2016),
e  conducted  a  single-center,  cross-sectional  study  using
elf-reported  questionnaires.  The  data  were  collected  from
utpatients  or  inpatients  in  Department  of  Cardiology,  Tokyo
 IN+Model
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Avoidance  behavior  associated  with  depressive  symptoms  in
Women’s  Medical  University  (TWMU)  Hospital  between  May
2010  and  March  2011.  Patients  who  have  deﬁbrillators  (ICDs
or  CRT-Ds)  were  included  in  this  study.  Some  patients  were
excluded:  those  were  judged  to  have  severe  physical  or
mental  problems  (e.g.,  serious  symptoms  of  heart  failure,
delirium,  or  dementia)  or  insufﬁcient  literacy  skills  by  cardi-
ologists,  and  patients  older  than  90  years.  Sixty-ﬁve  patients
were  excluded  because  they  did  not  complete  the  question-
naire,  resulting  in  data  for  119  (response  rate:  64.7%)  being
available  for  analysis.
Instruments
Demographic  and  clinical  characteristics.  Demographic  and
clinical  characteristics  were  collected  from  patients’  medi-
cal  records  to  identify  potential  confounders  for  depressive
symptoms.  Data  included  age,  sex,  living  situation,  employ-
ment  status,  cardiac  diseases  and  complications,  and  infor-
mation  about  devices  (i.e.,  type,  reason  for  implantation,
period  of  implantation,  and  experience  of  electric  shocks).
Avoidance  behaviors.  Avoidance  behaviors  were  evalu-
ated  using  questionnaires  we  developed  for  a  series  of  our
studies  based  on  a  previous  study  (Lemon  et  al.,  2004).
This  instrument  had  been  currently  under  development.  The
questionnaire  included  three  items:  (1)  ‘‘How  often  do  you
avoid  places  (e.g.,  trains  or  buses)  where  you  think  you
are  likely  to  get  a  shock?’’  (avoidance  of  places);  (2)  ‘‘How
often  do  you  avoid  objects  (e.g.,  cell  phones  or  microwave)
where  you  think  you  are  likely  to  get  a  shock?’’  (avoidance
of  objects);  and  (3)  ‘‘How  often  do  you  avoid  situations
(e.g.,  taking  a  shower)  where  you  think  you  are  likely  to
get  a  shock?’’  (avoidance  of  situations).  Each  item  was
scored  on  a  four-point  Likert-type  scale  (always  =  3,  usu-
ally  =  2,  rarely  =  1,  and  never  =  0).  The  total  score  of  the
three  items  was  denoted  as  avoidance  behaviors,  and  a
higher  score  amounted  to  greater  avoidance  (range:  0--9).
The  content  validity  of  the  questionnaire  was  discussed
among  researchers  including  cardiologists,  psychiatrists,
and  clinical  psychologists.  The  test-retest  interclass  Corre-
lation  Coefﬁcients  (ICC)  =  .61,  and  Cronbach’s  alpha  =  .60  in
our  data  for  another  previous  study  among  Japanese  outpa-
tients  with  ICDs  (Ichikura  et  al.,  2015).
Depressive  symptoms.  Depressive  symptoms  were  evalu-
ated  using  the  Beck  Depression  Inventory,  Version  II:  BDI-II
(Beck,  Steer,  &  Brown,  1996;  Kojima  et  al.,  2002).  The  BDI-II
measures  the  severity  of  depressive  symptoms  rather  than
the  presence  of  a  depressive  episode.  It  is  a  21-item  self-
rated  questionnaire  for  depressive  symptoms.  It  utilizes  a
four-point  Likert-type  scale  ranging  from  0  to  3  (overall
score  0--63).  A  score  of  0--13  is  classiﬁed  as  minimal  depres-
sive  symptoms,  14--19  as  mild,  20--28  as  moderate,  and
29--63  as  severe.  We  deﬁned  a  score  of  more  than  14  points
as  indicating  patients  with  depressive  symptoms.  The  reli-
ability  and  validity  of  this  questionnaire  were  sufﬁciently
supported  in  some  earlier  studies  (Beck  et  al.,  1996),  and
Cronbach’s  alpha  =  .92--.93.Please  cite  this  article  in  press  as:  Ichikura,  K.,  et  al.  Avoi
patients  with  implantable  cardioverter  deﬁbrillators.  Interna
http://dx.doi.org/10.1016/j.ijchp.2016.11.001
Procedure
We  conducted  continuous  sampling  from  all  eligible  patients
in  the  TWMU  Hospital.  Two  research  students  (KI  and
w
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2 PRESS
ents  with  ICDs  3
M)  who  were  not  involved  in  medical  practice  informed
atients  about  the  aim  of  this  study  and  obtained  their
ritten  consent.  The  questionnaires  were  completed  and
ollected  from  patients  after  they  agreed  to  participate.
he  researchers  assisted  those  patients  who  were  unable  to
rite  the  answers  themselves  because  of  physical  problems
uch  as  dysopia  or  upper-limb  dysfunction  to  keep  selection
ias  at  a  minimum.
All the  procedures  were  in  accordance  with  the  ethical
tandards  of  the  responsible  committees  on  human  experi-
entation  (institutional  and  national)  and  with  the  Helsinki
eclaration  of  1975,  as  revised  in  2000.  All  participants  were
olunteers  and  were  not  provided  with  any  incentives  to
articipate.  This  study  assured  participant  anonymity  and
as  approved  by  the  ethics  committee  of  TWMU  (1832)  and
aseda  University  (2012-157).
According  to  some  past  studies,  depressive  symptoms
ccur  in  24--46%  of  patients  with  ICDs  (Godemann  et  al.,
004;  Lang  et  al.,  2014;  Sears  &  Conti,  2002).  Using  the
bove  information  as  our  reference  range  for  depressive
ymptoms  and  assuming  depressive  symptoms  in  patients
ith  ICDs  without  avoidance  behaviors  to  be  20%  and  with
voidance  behaviors  to  be  40%,  we  needed  164  participants
or  80%  power  and  5%  signiﬁcance  levels.  One  hundred  and
inety-seven  patients  was  deemed  sufﬁcient,  even  if  20%  of
atients  did  not  agree  to  participate  or  did  not  complete  the
uestionnaire  (Sato,  2015).
tatistical  analysis
irst,  we  examined  the  frequency  distributions  of  all  demo-
raphic  and  clinical  characteristics.  Second,  we  examined
he  Cronbach’s  alpha  coefﬁcient  as  a measure  of  the  internal
onsistency  reliability  of  avoidance  behaviors  scores.  Then,
e  examined  the  frequency  of  three  avoidance  behaviors
nd  compared  each  other  using  Cochran’s  Q  test.  Third,
e  estimated  the  odds  ratios  (ORs)  and  95%  conﬁdence
ntervals  (CIs)  of  avoidance  behaviors  for  the  presence  of
epressive  symptoms  (BDI-II  ≥  14)  using  logistic  regression
odels.  Then,  we  sequentially  introduced  groups  of  varia-
les  into  the  model:  ﬁrst  demographic  and  clinical  variables
nd  then  avoidance  behaviors,  because  these  are  known
rom  previous  studies  to  be  associated  with  depressive
ymptoms  (Morys´ et  al.,  2016).  The  independent  variables
ncluded  in  this  model  were  based  on  a  priori  clinical  judg-
ent  and  the  existing  literature,  and  included  1)  age,  2)
ex,  3)  family  structure  (living  alone  vs.  living  with  fam-
ly),  4)  employment  status,  5)  presence  of  heart  failure,
nd  6)  having  experienced  electric  shock.  We  used  a  like-
ihood  ratio  test  to  determine  the  statistical  signiﬁcance  of
nteraction  terms  in  the  logistic  regression  models.  Multi-
ollinearity  was  assessed  using  the  variance  inﬂation  factor
VIF;  Katz,  2003).  A  VIF  exceeding  10  was  regarded  as  indi-
ating  serious  multicollinearity,  and  values  greater  than  4.0
ay  be  a  cause  for  concern  (Katz,  2003).  We  also  examined
n  identical  logistic  regression  model  except  for  patientsdance  behavior  associated  with  depressive  symptoms  in
tional  Journal  of  Clinical  and  Health  Psychology  (2016),
ith  CRT-Ds  to  show  that  we  can  achieve  consistent  results
n  the  subgroup.  We  conducted  all  analyses  using  R  ver-
ion  2.15.1.  with  the  R  package  ‘‘rpsychi’’  (R  Core  Team,
012).
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Total  recr uited  
(N = 221)  
Participants  
(n = 184) 
 Data available 
for analysis 
(n = 119 ) 
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Those  wit h phy sica l or mental problems (n = 34)  
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Those  wit h miss ing va lues  ( n = 65)  
Figure  1  Patient  recruitment  and  ﬂow  diagram.
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articipants’  characteristics
nfortunately,  we  stopped  recruiting  before  reaching  the
equired  number  of  participants  because  Waseda  Univer-
ity  ceased  the  dispatch  of  research  students  to  TWMU
ospital  because  of  the  Great  East  Japan  Earthquake  in
arch  2011.  Of  the  221  patients  with  an  ICD  or  CRT-D,  data
rom  184  participants  were  considered  potentially  eligible
Figure  1).
We  compared  the  demographic  and  clinical  characteris-
ics  of  participants  (Table  1).  Thirty-one  (26.1%)  patients  had
epressive  symptoms  (BDI  ≥  14)  among  the  ICD  recipients.
inety-two  (77.3%)  were  more  than  50-years-old,  86  (72.3%)
ere  men,  and  25  (21.0%)  lived  alone.  More  than  half  of  all
articipants  had  cardiac  myopathy  (n  =  63,  52.0%),  and  47
39.5%)  had  heart  failure.
requency  of  avoidance  behaviors
he  Cronbach’s  alpha  coefﬁcient  was  .65  for  the  avoid-
nce  behaviors  summary  score.  The  frequency  of  patients’
voidance  behaviors  is  shown  in  Figure  2.  Fifty-one  (42.8%)
atients  reported  ‘‘avoidance  of  places’’  with  responses  of
‘always’’  or  ‘‘usually’’,  34  (28.6%)  reported  ‘‘avoidance
f  objects’’,  and  63  (52.9%)  reported  ‘‘avoidance  of  situa-Please  cite  this  article  in  press  as:  Ichikura,  K.,  et  al.  Avoi
patients  with  implantable  cardioverter  deﬁbrillators.  Interna
http://dx.doi.org/10.1016/j.ijchp.2016.11.001
ions’’.  According  to  the  Cochran’s  Q  test,  the  frequency  of
voidance  of  places  and  avoidance  of  situations  were  sig-
iﬁcantly  higher  than  avoidance  of  objects  was  (Q  =  20.55,
 <  .05).
o
a
p
tavoidance  behaviors.
ssociation  between  avoidance  behaviors  and
epressive symptoms
he  logistic  regression  analysis  indicated  that  avoidance
ehaviors  was  related  to  depressive  symptoms  (Table  2),
ith  an  odds  ratio  of  1.31  (95%  conﬁdence  interval  [CI]
.06--1.62).  In  the  likelihood  ratio  test,  none  of  the  inter-
ctions  of  the  independent  variables  were  signiﬁcant.
vidence  for  multicollinearity  was  absent  because  the  VIF
or  independent  variables  in  this  model  was  less  than
.0  (Table  2).  The  subgroup  analysis  also  indicated  that
voidance  behaviors  and  living  alone  were  associated  with
ncreased  odds  for  depressive  symptoms  (OR  =  1.80,  95%  CI:
.24--2.61;  OR  =  20.02,  95%  CI  3.26--122.98)  (Table  3).
iscussion
ur  study  yielded  two  major  ﬁndings.  First,  our  results
emonstrated  that  avoidance  of  situations  appeared  in  more
han  50%  of  patients,  and  avoidance  of  situations  and  places
ccurred  at  a  higher  frequency  compared  with  avoidance
f  objects.  Second,  our  results  demonstrate  that  avoidance
ehavior  was  associated  with  depressive  symptoms  among
atients  with  ICDs,  and  the  same  result  was  also  conﬁrmed
y  the  subgroup  analysis  model,  which  excluded  patients
ith  CRT-Ds.
One  important  consequence  is  that  many  patients  suf-
er  from  avoidance  behaviors,  particularly  from  avoidancedance  behavior  associated  with  depressive  symptoms  in
tional  Journal  of  Clinical  and  Health  Psychology  (2016),
f  situations  and  places.  For  example,  agoraphobia  (i.e.,
voidance  of  places)  was  a  very  common  problem  of  ICD
atients  (Godemann  et  al.,  2004).  Other  studies  showed
hat  avoidance  of  situations,  including  physical  exercise,
ARTICLE IN PRESS+ModelIJCHP-82; No. of Pages 8
Avoidance  behavior  associated  with  depressive  symptoms  in  patients  with  ICDs  5
Table  1  Participants’  characteristics.
Characteristic Total  (N  =  119)  Without  depressive
symptoms  (n  =  88)
With  depressive
symptoms  (n  =  31)
n  (%)  n  (%)  n  (%)
Age
20--29  years  6  (5.0)  4  (4.5)  2  (6.5)
30--39 years  9  (7.6)  7  (8.0)  2  (6.5)
40--49 years 12  (10.1)  10  (11.4)  2  (6.5)
50--59 years 21  (17.6)  14  (15.9)  7  (22.6)
60--69 years 33  (27.7)  25  (28.4)  8  (25.8)
70--89 years  38  (31.9)  28  (31.8)  10  (32.2)
Sex
Men 86  (72.3)  65  (73.9)  21  (67.7)
Women 33  (27.7)  23  (26.1)  10  (32.3)
Family structure
Living  alone  25  (21.0)  14  (15.9)  11  (35.5)
Living with  family  94  (79.0)  74  (84.1)  20  (64.5)
Employment status
Unemployed  71  (60.0)  49  (55.7)  22  (71.0)
Employed 48  (40.3)  39  (44.3)  9  (29.0)
Underlying cardiac  disease
Cardiac  myopathy  63  (52.9)  43  (48.9)  20  (64.5)
Ischemic cardiac  disease  28  (23.5)  18  (20.5)  10  (32.3)
Idiopathic ventricular  ﬁbrillation  8  (6.7)  7  (7.9)  1  (3.2)
Others 20  (16.8)  20  (22.7)  0  (0)
Complicationsa
Heart  failure  47  (39.5)  32  (36.4)  15  (48.4)
Hypertension 27  (22.7)  19  (21.6)  8  (25.8)
Diabetes 19  (16.0)  15  (17.0)  4  (12.9)
Chronic kidney  disease  16  (13.7)  12  (14.0)  4  (12.9)
Implanted device
ICDb 74  (62.2)  56  (63.6)  18  (58.1)
CRT-Dc 45  (37.8)  32  (36.4)  13  (41.9)
Primary prevention
Yes  46  (39.7)  32  (37.6)  14  (45.2)
No 73  (61.3)  56  (63.6)  17  (54.8)
Experienced electric  shocks
Yes  48  (40.3)  35  (39.8)  13  (41.9)
No 71  (60.0)  53  (60.2)  18  (58.1)
Period of  implantation
<  1  year  27  (22.7)  23  (26.1)  4  (12.9)
≥ 1  years,  <  5  years  49  (41.2)  34  (38.6)  15  (48.4)
≥ 5  years  43  (36.1)  31  (35.2)  12  (38.7)
Note.
a The complications data were overlapped;
b
h
wICD = implantable cardioverter deﬁbrillator;
c CRT-D = cardiac resynchronization therapy deﬁbrillator.
sexual  activity,  or  taking  a  shower,  occurred  frequently  and
directly  interrupted  patients’  daily  life  (Cutitta  et  al.,  2014;
Lemon  et  al.,  2004).  In  addition,  patients  would  like  to  copePlease  cite  this  article  in  press  as:  Ichikura,  K.,  et  al.  Avoi
patients  with  implantable  cardioverter  deﬁbrillators.  Interna
http://dx.doi.org/10.1016/j.ijchp.2016.11.001
with  avoidance  behaviors  by  fear  of  ICDs  (Humphreys,  Lowe,
Rance,  &  Bennett,  2016).  Therefore,  avoidance  of  places
and  situations  were  difﬁcult  problems  for  patients  with  ICDs.
a
a
CAnother  ﬁnding  supports  our  primary  hypothesis  that  the
eight  of  avoidance  tendency  is  more  likely  to  be  associated
ith  depressive  symptoms.  One  explanation  is  that  avoid-dance  behavior  associated  with  depressive  symptoms  in
tional  Journal  of  Clinical  and  Health  Psychology  (2016),
nce  behaviors  can  enhance  depressive  symptoms  and  they
re  mediated  by  activation  of  catastrophic  interpretations.
atastrophic  thinking,  such  as  a  fear  of  dying  increased
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Table  2  Depressive  symptoms  among  patients  with  implantable  cardioverter  deﬁbrillators  and  cardiac  resynchronization  ther-
apy deﬁbrillators  (N  =  119).
Variable Adjusted  ORa SEb
95%  CIc p
CIc Lower  Upper
Demographic  and  clinical  variables
Men  (vs.  women)  0.71  .51  0.26  1.91  .49
Older (vs.  younger:  <  65  years) 0.95  .46  0.39  2.31  .90
Living alone  (vs.  living  with  family) 2.68 .52 0.97 7.37  .06
Unemployed  (vs.  employed) 1.71 .48 0.67 4.34 .26
Without  heart  failure  (vs.  heart  failure)  0.83  .46  0.33  2.05  .68
Experienced  electric  shock  (vs.  no)  1.20  .48  0.47  3.03  .71
Avoidance behaviors
Avoidance  total  scored 1.31  .11  1.06  1.62  .01*
Note.
a OR = odds ratio;
b SE = standard error;
c Conﬁdence interval;
d Avoidance total score with continuous variable;
* p < .05.
Table  3  Depressive  symptoms  only  among  patients  with  implantable  cardioverter  deﬁbrillators  (N  =  74).
Variable Adjusted  ORa SEb
95%  CIc p
Lower  Upper
Demographic  and  clinical  variables
Men  (vs.  women) 1.51 .79  0.32  7.12  .61
Older (vs.  younger:  <  65  years) 1.17 .68 0.31  4.49  .81
Living alone  (vs.  living  with  family) 20.02 .93  3.26  122.98  .00*
Unemployed  (vs.  employed) 0.80 .70 0.21  3.12  .75
Without heart  failure  (vs.  heart  failure)  2.51  .91  0.42  14.92  .31
Experienced  electric  shock  (vs.  no)  1.10  .67  0.29  4.13  .89
Avoidance behaviors
Avoidance  total  scored 1.80  .19  1.24  2.61  .00*
Note.
a OR = odds ratio;
b SE = standard error;
c CI = conﬁdence interval;
d
b
d
o
i
s
c
r
o
H
u
a
o
s
(
a
a
t
c
a
n
T
n
r
o
o
s
wAvoidance total score with continuous variable;
* p < .05.
y  avoidance  behaviors,  is  deﬁned  as  a  factor  related  to
epressive  symptoms  per  the  second  wave  of  cognitive  the-
ry  (Beck,  1987;  Kovacs  &  Beck,  1978).  Another  explanation
s  that  avoidance  behaviors  can  directly  lead  to  depres-
ive  symptoms  among  patients  with  ICDs.  According  to  some
ognitive  behavioral  models  for  depressive  symptoms,  expe-
iential  avoidance  naturally  contributes  to  the  worsening
f  depressive  symptoms  (Jacobson  et  al.,  2006;  Lesinsohn,
oberman,  Teri,  &  Hautzinger,  1985).
In  contrast,  the  cause-and-effect  relationship  remains
nclear  due  to  the  use  of  the  cross-sectional  method.  Avoid-
nce  behaviors  can  occur  because  of  depressive  symptoms,
r  they  can  moderate  the  relationship  between  depres-Please  cite  this  article  in  press  as:  Ichikura,  K.,  et  al.  Avoi
patients  with  implantable  cardioverter  deﬁbrillators.  Interna
http://dx.doi.org/10.1016/j.ijchp.2016.11.001
ive  and  anxiety  symptoms  per  the  fear-avoidance  model
Seekatz,  Meng,  Bengel,  &  Faller,  2015).  Indeed,  behavioral
ctivation  that  is  focused  on  avoidance  behavior  is  typically
c
b
cn  effective  treatment  for  patients  with  depressive  symp-
oms  (Hunot  et  al.,  2013).  Therefore,  avoidance  behaviors
ould  be  amenable  to  treatment  for  patients  with  ICDs  who
t  risk  for  depression.
Our  study  had  several  limitations.  First,  causality  can-
ot  be  inferred  due  to  the  cross-sectional  study  design.
herefore,  longitudinal  or  randomized  controlled  trials  are
eeded  in  the  future.  Second,  potential  instrument  bias  and
ecall  bias  might  exist  due  to  our  measures.  The  instrument
f  avoidance  behaviors  had  not  been  standardized,  and  had
nly  a three-items  with  a  small  range.  Additionally,  all  mea-
ures  comprised  self-completed  questionnaires.  However,
e  evaluated  content  validity  with  sufﬁcient  discussion,  anddance  behavior  associated  with  depressive  symptoms  in
tional  Journal  of  Clinical  and  Health  Psychology  (2016),
onﬁrmed  internal  consistency  reliability.  Third,  selection
ias  might  have  occurred  due  to  implementing  a  single-
enter  study  in  Japan.  The  hospital  might  have  had  a
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high  frequency  of  severe  heart  diseases  compared  to  other
hospitals,  which  typically  have  28%  patients  with  cardiac
myopathy  (The  Japanese  Circulation  Society,  2011).  How-
ever,  the  hypothetical  model  was  supported  by  the  subgroup
analysis  that  was  conducted  with  patients  with  mild  heart
failure.  Fourth,  there  was  insufﬁcient  power  because  of  the
small  sample  size.  We  regret  that  our  study  was  forced
to  stop  recruiting  due  to  the  earthquake.  Fifth,  the  logis-
tic  regression  model  assumed  in  this  study  was  inadequate
to  determine  the  relationship  between  avoidance  behaviors
and  depressive  symptoms.  We  did  not  measure  factors  for
depressive  symptoms  such  as  family  history  of  depressive
disorder.
Our  study  suggests  that  avoidance  behaviors  may  be  a
potential  controllable  risk  factor  for  patients  with  depres-
sive  symptoms.  Sears  and  Conti  (2002)  indicated  there  is
a  relationship  between  avoidance  behaviors  and  anxiety
symptoms.  Therefore,  we  should  develop  a  model  of  ICD
patients’  psychological  distress  including  avoidance  behav-
iors,  depressive  symptoms,  and  anxiety  symptoms.  Future
research  could  include  the  development  of  psychological
care  programs  focused  on  avoidance  behaviors,  as  well  as
longitudinal  or  randomized  controlled  studies.
This  is  the  ﬁrst  study  to  clarify  the  relationship  between
avoidance  behaviors  and  depressive  symptoms  in  patients
with  ICDs,  although  there  were  a  few  methodological  limi-
tations.  High-quality  studies  that  provide  scientiﬁc  evidence
regarding  the  mechanism  for  the  development  of  depressive
symptoms  among  patients  with  ICDs  should  be  conducted  in
the  future.
Acknowledgments
We  are  grateful  to  Yasuyuki  Okumura  of  the  Institute  for
Health  Economics  and  Policy,  all  Suzuki  laboratory  members
at  Waseda  University,  and  the  Psychosomatic  Medicine  Study
Group  in  Cardiology  at  Tokyo  Women’s  Medical  University
for  supporting  our  research  program.  Additionally,  we  would
like  to  thank  all  collaborators  in  the  Department  of  Cardiol-
ogy  at  Tokyo  Women’s  Medical  University  hospitals  for  their
assistance  in  recruiting  participants.
References
Alba, A. C., Braga, J., Gewarges, M., Walter, S. D., Guyatt, G. H.,
& Ross, H. J. (2013). Predictors of mortality in patients with an
implantable cardiac deﬁbrillator: A systematic review and meta-
analysis. The Canadian Journal of Cardiology,  29,  1729--1740.
http://dx.doi.org/10.1016/j.cjca.2013.09.024
Beck, A. T. (1987). Cognitive models of depression. The Journal of
Cognitive Psychotherapy,  1, 5--37.
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the
Beck Depression Inventory--Second Edition.  San Antonio: The
Psychological Corporation.
Chen, S., Ling, Z., Kiuchi, M. G., Yin, Y., & Krucoff, M. W.
(2013). The efﬁcacy and safety of cardiac resynchronization
therapy combined with implantable cardioverter deﬁbrillator for
heart failure: A meta-analysis of 5674 patients. Europace, 15,Please  cite  this  article  in  press  as:  Ichikura,  K.,  et  al.  Avoi
patients  with  implantable  cardioverter  deﬁbrillators.  Interna
http://dx.doi.org/10.1016/j.ijchp.2016.11.001
992--1001. http://dx.doi.org/10.1093/europace/eus419
Connolly, S. J., Hallstrom, A. P., Cappato, R., Schron, E. B., Kuck,
K. H., Zipes, D. P., Greene, H. L., Boczor, S., Domanski, M.,
Follmann, D., Gent, M., & Roberts, R. S. (2000). Meta-analysis of PRESS
ents  with  ICDs  7
the implantable cardioverter deﬁbrillator secondary prevention
trials. European Heart Journal, 21,  2071--2078.
utitta, K. E., Woodrow, L. K., Ford, J., Shea, J., Fischer, A.,
Hazelton, G., & Sears, S. F. (2014). Shocktivity: Ability and
avoidance of daily activity behaviors in ICD patients. Journal of
Cardiopulmonary Rehabilitation and Prevention,  34, 241--247.
http://dx.doi.org/10.1097/HCR.0000000000000055
e Ornelas Maia, A. C. C., Soares-Filho, G., Pereira, V., Nardi, A.
E., & Silva, A. C. (2013). Psychiatric disorders and quality of
life in patients with implantable cardioverter deﬁbrillators: A
systematic review [Online]. The Primary Care Companion for
CNS Disorders. http://dx.doi.org/10.4088/PCC.12r01456
odemann, F., Ahrens, B., Behrens, S., Berthold, R., Gandor, C.,
Lampe, F., & Linden, M. (2001). Classic conditioning and dysfunc-
tional cognitions in patients with panic disorder and agoraphobia
treated with an implantable cardioverter/deﬁbrillator. Psycho-
somatic Medicine, 63,  231--238.
odemann, F., Butter, C., Lampe, F., Linden, M., Schlegl, M.,
Schultheiss, H. P., & Behrens, S. (2004). Panic disorders and
agoraphobia: Side effects of treatment with an implantable car-
dioverter/deﬁbrillator. Clinical Cardiology,  27, 321--326.
eller, S. S., Ormont, M. A., Lidagoster, L., Sciacca, R. R., & Stein-
berg, S. (1998). Psychosocial outcome after ICD implantation: A
current perspective. Pacing and Clinical Electrophysiology, 21,
1207--1215.
umphreys, N., Lowe, R., Rance, J., & Bennett, P. (2016). Liv-
ing with an implantable cardioverter deﬁbrillator: The patients’
experience. Heart & Lung: The Journal of Acute and Critical
Care, 45,  34--40.
unot, V., Moore, T. H. M., Caldwell, D. M., Furukawa, T. A.,
Davies, P., Jones, H., Honyashiki, M., Chen, P., Lewis, G., &
Churchill, R. (2013). Third wave’’ cognitive and behavioural
therapies versus other psychological therapies for depres-
sion [Online]. The Cochrane Database of Systematic Reviews,
http://dx.doi.org/10.1002/14651858.CD008704.pub2
chikura, K., Kobayashi, S., Matsuoka, S., Suzuki, T., Nishimura,
K., Shiga, T., Hagiwara, N., Ishigooka, J., & Suzuki, S. (2015).
Department and ﬁrst validation of ‘‘Perceptions of Implantable
Cardioverter Deﬁbrillators Scale’’. The Japanese Journal of Car-
diac Rehabilitation,  20,  171--178.
ngles, J., Sarina, T., Kasparian, N., & Semsarian, C. (2013).
Psychological wellbeing and posttraumatic stress associated
with implantable cardioverter deﬁbrillator therapy in young
adults with genetic heart disease. International Journal
of Cardiology,  168, 3779--3784. http://dx.doi.org/10.1016/
j.ijcard.2013.06.006
acobson, N. C., Martell, C. R., & Dimidjian, S. (2006). Behavioral
activation treatment for depression: Returning to contex-
tual roots. Clinical Psychology: Science and Practice, 8,
255--270.
acobson, N. C., & Newman, M. G. (2014). Avoidance mediates
the relationship between anxiety and depression over a decade
later. Journal of Anxiety Disorders, 28,  437--445. http://dx.
doi.org/10.1016/j.janxdis.2014.03.007
atz, M. H. (2003). Multivariable analysis: A primer for readers of
medical research. Annals of Internal Medicine, 138, 644--650.
ojima, M., Furukawa, T. A., Takahashi, H., Kawai, M., Nagaya,
T., & Tokudome, S. (2002). Cross-clutural validation of the
Beck Depression Inventory-II in Japan. Psychiatry Research, 110,
291--299.
ovacs, M., & Beck, A. T. (1978). Maladaptive cognitive struc-
tures in depression. The American Journal of Psychiatry,  135,
525--533.
ang, S., Becker, R., Wilke, S., Hartmann, M., Herzog, W., &dance  behavior  associated  with  depressive  symptoms  in
tional  Journal  of  Clinical  and  Health  Psychology  (2016),
Löwe, B. (2014). Anxiety disorders in patients with implantable
cardioverter deﬁbrillators: Frequency, course, predictors, and
patients’ requests for treatment. Pacing and Clinical Electro-
physiology, 37,  35--47. http://dx.doi.org/10.1111/pace.12276
 IN+ModelI
8
L
L
L
M
M
M
P
R
S
S
S
S
S
T
T
T
v
v
WARTICLEJCHP-82; No. of Pages 8
 
emon, J., Edelman, S., & Kirkness, A. (2004). Avoidance behaviors
in patients with implantable cardioverter deﬁbrillators. Heart &
Lung: The Journal of Critical Care, 33,  176--182.
esinsohn, P. M., Hoberman, H. M., Teri, L., & Hautzinger, M. (1985).
An integrative theory of depression.  Orlando: Academic Press.
uyster, F. S., Hughes, J. W., & Gunstad, J. (2009). Depres-
sion and anxiety symptoms are associated with reduced
dietary adherence in heart failure patients treated with an
implantable cardioverter deﬁbrillator. The Journal of Car-
diovascular Nursing, 24,  10--17. http://dx.doi.org/10.1097/
01.JCN.0000317469.63886.24
agyar-Russell, G., Thombs, B. D., Cai, J. X., Baveja, T., Kuhl,
E. A., Singh, P. P., Montenegro Braga Barroso, M., Arthurs,
E., Roseman, M., Amin, N., Marine, J. E., & Ziegelstein,
R. C. (2011). The prevalence of anxiety and depression in
adults with implantable cardioverter deﬁbrillators: A system-
atic review. Journal of Psychosomatic Research, 71,  223--231.
http://dx.doi.org/10.1016/j.jpsychores.2011.02.014
orken, I. M., Bru, E., Norekvål, T. M., Larsen, A. I., Idsoe, T., &
Karlsen, B. (2014). Perceived support from healthcare profes-
sionals, shock anxiety and post-traumatic stress in implantable
cardioverter deﬁbrillator recipients. Journal of Clinical Nursing,
23, 450--460.
orys´, J. M., Pa˛chalska, M., Bellwon, J., & Gruchała, M.
(2016). Cognitive impairment, symptoms of depression, and
health-related quality of life in patients with severe sta-
ble heart failure. International Journal of Clinical and
Health Psychology,  16,  230--238. http://dx.doi.org/10.1016/
j.ijchp.2016.03.002
auli, P., Wiedemann, G., Dengler, W.,  Blaumann-Benninghoff,
G., & Kühlkamp, V. (1999). Anxiety in patients with an
automatic implantable cardioverter deﬁbrillator: What differ-
entiates them from panic patients? Psychosomatic Medicine, 61,
69--76. http://dx.doi.org/10.1111/jocn.12200
 Core Team. (2012). R: A language and environment for statis-
tical computing.  Vienna, Austria: R Foundation for Statistical
Computing.
ato, I. (2015). . The Art & Science of Social Research (Vol. 1) Tokyo:
University of Tokyo Press.
ears, S. F., & Conti, J. B. (2002). Quality of life and psychologicalPlease  cite  this  article  in  press  as:  Ichikura,  K.,  et  al.  Avoi
patients  with  implantable  cardioverter  deﬁbrillators.  Interna
http://dx.doi.org/10.1016/j.ijchp.2016.11.001
functioning of ICD patients. Heart (British Cardiac Society), 87,
488--493.
eekatz, B., Meng, K., Bengel, J., & Faller, H. (2015). Is there a
role of depression in the fear-avoidance model? A structural PRESS
K.  Ichikura  et  al.
equation approach. Advance online. Psychology, Health &
Medicine, http://dx.doi.org/10.1080/13548506.2015.1111392
halaby, A., Brumberg, G., El-Saed, A., & Saba, S. (2012). Mood
disorders and outcome in patients receiving cardiac resynchro-
nization therapy. Pacing and Clinical Electrophysiology, 35,
294--301. http://dx.doi.org/10.1111/j.1540-8159.2011.03304.x
tarrenburg, A., Kraaier, K., Pedersen, S., Scholten, M., & Van
Der Palen, J. (2014). Psychological indices as predictors for
phantom shocks in implantable cardioverter deﬁbrillator recip-
ients. Pacing and Clinical Electrophysiology, 37,  768--773.
http://dx.doi.org/10.1111/pace.12343
an, V. H., Wilton, S. B., Kuriachan, V., Sumner, G. L., & Exner,
D. V. (2014). Impact of programming strategies aimed at
reducing non-essential implantable cardioverter deﬁbrillator
therapies on mortality: A systematic review and meta-analysis.
Circulation: Arrhythmia and Electrophysiology, 7, 164--170.
http://dx.doi.org/10.1161/CIRCEP.113.001217
he Japanese Circulation Society. (2011). Guidelines
for non-pharmacotherapy of cardiac arrhythmias.
Retrieved October 25, 2016 from http://www.j-circ.or.jp/
guideline/pdf/JCS2011 okumura h.pdf
zeis, S., Kolb, C., Baumert, J., Reents, T., Zrenner, B., Deisen-
hofer, I., Ronel, J., Andrikopoulos, G., & Ladwig, K. H. (2011).
Effect of depressive symptoms on mortality in implantable car-
dioverter deﬁbrillator recipients: Findings from the prospective
LICAD study. Pacing and Clinical Electrophysiology, 34, 991--997.
http://dx.doi.org/10.1111/j.1540-8159.2011.03081.x
an den Broek, K. C., Tekle, F. B., Habibovic´, M., Alings, M., van
der Voort, P. H., & Denollet, J. (2013). Emotional distress,
positive affect, and mortality in patients with an implantable
cardioverter deﬁbrillator. International Journal of Cardiology,
165,  327--332. http://dx.doi.org/10.1016/j.ijcard.2011.08.071
on Känel, R., Baumert, J., Kolb, C., Cho, E. Y. N., & Lad-
wig, K. H. (2011). Chronic posttraumatic stress and its
predictors in patients living with an implantable cardioverter
deﬁbrillator. Journal of Affective Disorders, 131, 344--352.
http://dx.doi.org/10.1016/j.jad.2010.12.002
hang, W.,  Albert, C. M., Sears, S. F., Lampert, R., Conti, J. B.,
Wang, P. J., Singh, J. P., Ruskin, J. N., Muller, J. E., & Mittleman,
M. A. (2005). Depression as a predictor for appropriate shocksdance  behavior  associated  with  depressive  symptoms  in
tional  Journal  of  Clinical  and  Health  Psychology  (2016),
among patients with implantable cardioverter-deﬁbrillators:
Results from the Triggers of Ventricular Arrhythmias (TOVA)
study. Journal of the American College of Cardiology,  45,
1090--1095.
